Irmukin

药品简介

Originator: Tagrisso by AstraZeneca · Manufacturer: Genvio Pharma. Indication & Dosage: Irmukin (Osimertinib), generic Tagrisso is a prescription medicine used to treat advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Irmukin manufactured by Genvio Pharma Ltd. in Bangladesh. Osimertinib has to take orally once daily with or without food. Side Effects: The most common adverse reactions (≥25%) of Osimertinib are: Diarrhea , rash , dry skin , nail toxicity , stomatitis and reduced appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。